| 00:00 | Symposium: Lessons Learned about COVID-19 |
| 105.4 |
Immunogenetics (HLA and ABO) Lori Jeanne West, Canada |
| 105.6 |
Global Impact of COVID-19 on Transplantation Alexandre Loupy, France |
| 105.1 |
Virology, Epidemiology and Clinical Course Olivia S. Kates, United States |
| 105.2 |
Organ Specific Involvement of COVID-19 Aneesha Anand Shetty, United States |
| 105.3 |
Diagnostics: PCR, Antigen Detection and Serology Robin Patel, United States |
| 105.5 |
Therapeutics & Vaccines Michael G. Ison, United States |
| 00:00 | Symposium: Transplanting in the Era of COVID-19 |
| 110.2 |
When a Recipient with COVID-19 Can Proceed to Transplant Paolo Antonio Grossi, Italy |
| 110.1 |
Donor Screening and the Risk of Virus Transmission Thomas D. Mone, United States |
| 110.4 |
Transplantation in the Hot Zone Jean C. Emond, United States |
| 110.3 |
Lung Transplantation for COVID-19 Jingyu Chen, People's Republic of China |
| 110.5 |
Transplantation and Ethical Issues in the COVID Era: Doing the right thing depends on location, resources and disease burden Peter G. Stock, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Innate and Adaptive Immunity |
| 211.1 |
Gasdermin-D mutation is protective against renal ischemia reperfusion injury Jennifer Li, Australia |
| 211.5 (P-2.74 in Journal) |
Oral administration of nano-sized silicon particles attenuates oxidative stress and ischemia-reperfusion injury in a rat model: A novel hydrogen administration method Masataka Kawamura, Japan |
| 211.3 |
Modulation of the IL-33/ST2 axis for regulatory T cell therapy in transplantation Kento Kawai, United Kingdom |
| 211.4 |
Development of fully differentiated pancreatic organoids from hiPSCs for type 1 diabetes cell therapy Giuseppe Pettinato, United States |
| 00:15 - 02:00 | State-of-the-Art Session: Tissue-Resident Lymphocytes |
| 220.1 |
Formation and plasticity of tissue resident memory populations in human allografts revealed by single cell analysis and serial TCR sequencing Megan Sykes, United States |
| 220.2 |
Antigen presentation by tissue resident APC Adrian E. Morelli, United States |
| 220.3 |
Reshaping T cell memory with lymphoablation Anna Valujskikh, United States |
| 00:15 - 02:00 | State-of-the-Art Session: Expanding the Donor Pool, Pushing the Limits |
| 222.2 |
Use of DCD organs in heart and lung transplant Gregory I Snell, Australia |
| 222.1 |
Use of HCV positive organs into HCV negative recipients David Goldberg, United States |
| 222.3 |
Transplant outcomes from older donors > Age 60 Colleen L. Jay, United States |
| 07:30 - 08:15 | Oral Abstracts Session: Immune Regulation and Outcomes |
| 251.2 |
Discovery of pMHC epitopes for directly alloreactive T cells Eric Taeyoung ES Son, Australia |
| 251.3 |
The Prediction of Kidney Allograft Acute Rejection Based on Recipient Peripheral Blood Whole Transcriptome Profiling and Three mRNA Molecular Signatures Liao Minxue, People's Republic of China |
| 251.1 |
Elucidating the role of hypoxia in regulatory T cell function Marie Sion, United Kingdom |
| 08:15 - 10:00 | State-of-the-Art Session: Managing Immunosuppression When Things Go Wrong |
| 261.1 |
Managing IS in recipients with a failing graft Sangho Lee, Korea |
| 261.3 |
Managing IS in recipients treated for malignancies Daniel Seron, Spain |
| 261.2 |
Managing IS in recipients with complex infections Peter Chin-Hong, United States |
| 08:15 - 10:00 | State-of-the-Art Session: Banff 2019 Update for Allograft Rejection |
| 262.1 |
Liver (morphology) Andrew Clouston, Australia |
| 262.4 |
Kidney (molecular) Carmen Lefaucheur, France |
| 262.3 |
Kidney (morphology) Hyeon Joo Jeong, Korea |
| 262.2 |
Liver (molecular phenotyping) Alberto Sanchez-Fueyo, United Kingdom |
| 13:00 - 14:30 | Workshop Session: Specific Challenges in Pediatric Transplantation |
| 277.1 |
Research in paediatric transplantation Stephen Alexander, Australia |
|
Dr. Alexander Q&A discussion (4 minutes) - -, |
| 277.2 |
Transition Lars Pape, Germany |
| 277.3 |
Adherence Bethany J. Foster, Canada |
| 277.4 |
Steroids and growth Ryszard Grenda, Poland |
| 14:30 - 15:15 | Oral Abstracts Session: Biomarkers and Omics |
| 281.3 |
Single cell transcriptomic analysis for a better understanding of human CD8+ regulatory T cells Céline Serazin, France |
| 281.1 |
Transplantation of older organs transfers senescence Jasper Iske, Germany |
| 281.5 (P-2.125 in Journal) |
TCR repertoire sequencing of total T cells and circulating follicular helper T cells in kidney transplant recipients Patricia Almendro Vázquez, Spain |
| 281.2 |
Diagnosis of kidney transplant rejection by tracking donor-reactive T-cell clones in the post-transplant biopsy, blood and urine samples Joseph R. Leventhal, United States |
| 14:30 - 15:15 | Oral Abstracts Session: Established IS |
| 282.1 |
Country-dependent outcome differences after kidney transplantation in France vs. Germany – An additional analysis of the Athena study Barbara Suwelack, Germany |
| 282.3 |
Correlation of trough level compliance and protection of renal function after liver transplantation – A post-hoc analysis from the Hephaistos study Björn Nashan, Germany |
| 282.2 |
The risk of post-KT outcomes by induction choice differ between older and younger KT recipients JiYoon Ahn, United States |
| 282.4 |
Panel reactive antibody and the association of early steroid withdrawal with kidney transplant outcomes Sunjae Bae, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Experimental and Preclinical Immunosuppression |
| 312.2 |
Targeting inflammatory monocytes by immune-modifying nanoparticles prevents acute kidney allograft rejection Christina Lai, Australia |
| 312.4 |
ABO self-tolerance in a mouse model: Evidence of tolerance at B cell but not T cell level Ibrahim Adam, Canada |
| 312.3 |
Carfilzomib and lulizumab-based desensitization prolongs allograft survival in sensitized non-human primates kidney transplantation model Jean Kwun, United States |
| 07:30 - 08:15 | Oral Abstracts Session: Deceased Organ Donation |
| 352.3 |
Settling the difference: Analysis of kidney graft function discordance at transplant from deceased donor paired kidneys Essa Abuhelaiqa, Qatar |
| 07:30 - 08:15 | Oral Abstracts Session: Infectious Diseases |
| 353.5 (P-9.02 in Journal) |
Impact of non-active hepatitis B on patient survival after renal transplantation Marcel RG Naik, Germany |
| 353.2 |
A recent diagnosis of tuberculosis is a risk factor for post-transplant morbidity & mortality after liver transplantation: A propensity score match-based analysis Pradez Sapkota, India |
| 353.3 |
Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab Hyunwook Kwon, Korea |
| 353.4 |
Gram negative blood stream infection in renal transplant recipients: Risk factors and outcome from a transplant center in Pakistan Sunil Kumar Dodani, Pakistan |
| 08:15 - 10:00 | State-of-the-Art Session: The Future is Now… Immune Regulation in Transplantation |
| 360.1 |
The Regulation of Immune Tolerance by FOXP3 - basic Ling Lu, People's Republic of China |
| 360.2 |
Intragraft immune regulation protects transplants under sub-therapeutic immunosuppression Paloma Riquelme, Germany |
| James Alexander Hutchinson, Germany |
| 360.3 |
Clinical experience of Treg therapy Fadi Issa, United Kingdom |
| 08:15 - 10:00 | State-of-the-Art Session: The Future of Anesthesia and ICU in Organ Donation |
| 362.1 |
Neurosurgery, critical care and anesthesia: integrated support for organ donation in China Xiaoli Fan, People's Republic of China |
| 362.3 |
How manage organ donation in ICUs during COVID 19 times Marco Sacchi, Italy |
| 362.2 |
How can artificial intelligence, robotics and blockchain improve donor maintenance and treatment? Jordi Colomer, Spain |
| 14:30 - 15:15 | Oral Abstracts Session: Immune Regulation and Tolerance I |
| 381.1 |
Treg use the PD-1-PD-L1 axis for lymphatic transendothelial migration Wenji Piao, United States |
| 381.2 |
Donor liver plasmacytoid dendritic cells promote effector T cell exhaustion and augment Treg responses in mouse spontaneous liver transplant tolerance Ryosuke Nakano, United States |
| 381.3 |
Lymph node stromal laminin alpha 5 regulates adaptive immunity Lushen Li, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Novel Insights in Allorecognition |
| 391.3 |
Non-HLA allorecognition and graft loss Roman Reindl-Schwaighofer, Austria |
| 391.2 |
T-cell allorecognition Gavin Pettigrew, United Kingdom |
| 391.1 |
Innate allorecognition Fadi G. Lakkis, United States |
| 15:15 - 17:00 | State-of-the-Art Session: How Sex Impacts Post-Transplant Course |
| 392.2 |
Sex differences in infection risks and vaccine responses Deepali Kumar, Canada |
| 392.1 |
Sex differences in cancer risk post-transplant Anna Buxeda, Spain |
| 392.3 |
Sex and the heart: Major cardiovascular events in transplantation Darshana Dadhania, United States |
| 15:15 - 17:00 | State-of-the-Art Session: VCA: Cutting Edge Advances and Applications |
| 393.1 |
Calcineurin-free immunosuppression in VCA – Outcomes and opportunities Linda C. Cendales, United States |
| 393.2 |
Regenerative surgery – The new realm Giuseppe Orlando, United States |
| 393.3 |
Cell targeted nanoimaging for graft surveillance – Advances in solid organ and VCA applications Jelena M. Janjic PhD, United States |
| 393.4 |
Biomarker surrogates for immune monitoring of VCA Helen Stark, United Kingdom |
| 23:30 - 00:15 | Oral Abstracts Session: Living Organ Donation |
| 411.3 |
When length becomes less: Minimum renal artery length required in left laparoscopic live donor nephrectomy Anant Kumar, India |
| 411.1 |
Impact of extended living donor criteria on donor safety in living donor liver transplantation Joo Dong Kim, Korea |
| 411.2 |
Evolution of right laparoscopic nephrectomy: Report of a tertiary care center in Mexico LORENA NORIEGA-SALAS, Mexico |
| 411.4 |
Determination of type 2 diabetes mellitus risk in potential living kidney donors: A single center protocol and experience Golnaz G Friedman, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Cell and Novel Therapies |
| 412.1 |
Human mesenchymal-stem-cells derived exosomes play important roles in enhancing CB-treg suvival and functional stability Juan Zhang, People's Republic of China |
| 412.3 |
Targeting CD4+ T cell metabolism provides an effective and age-specific immunosuppression Yeqi Nian, People's Republic of China |
| 412.4 |
Long-term follow-up of a phase 2 clinical trial to induce tolerance in living donor renal transplant recipients Joseph R. Leventhal, United States |
| 00:15 - 02:00 | State-of-the-Art Session: Preventable Infections - An Ounce of Prevention... |
| 420.2 |
Screening and decolonization of MDROs pre-transplant: Is there a role? Stephanie Pouch, United States |
| 420.1 |
Respiratory viruses - Impact on our recipients Michael G. Ison, United States |
| 420.3 |
Keeping the fungi out of the transplant ward Monica Slavin, Australia |
| 00:15 - 02:00 | Workshop Session: Upcoming Issues in the Diagnosis of Transplant Rejection |
| 423.3 |
Dilemmas in renal allograft biopsy diagnosis Brian J Nankivell, Australia |
| 423.2 |
Gene expression in transplant tissue and body fluid Michael Mengel, Canada |
| 423.1 |
Digital pathology and machine learning in renal transplant pathology Alton "Brad" Farris, United States |
| 06:00 - 07:30 | Workshop Session: Unique Aspects of Organ Donation and Assessment in Pediatric Transplantation |
| 442.1 |
Risks for the living donor Michael Kaabak, Russian Federation |
| 442.2 |
Culture and religious perspectives Jun Oh, Germany |
| 442.4 |
ABO- and HLA- Incompatible transplantation Seiichiro Shishido, Japan |
| 442.3 |
Challenges of small paediatric donors Nam-Joon Yi, Korea |
| 07:30 - 08:15 | Oral Abstracts Session: Immune Regulation and Tolerance II |
| 451.3 |
PD-L1 / PD-1 interactions are critical for tolerance induction in primed skin graft recipients following liver-directed MHC class I gene transfer Mario L Leong, Australia |
| 451.2 |
Identification and isolation of human HLADR+ CD27+ Treg as xeno-antigen Treg subset for xenotransplantation Xiaoqian Ma, People's Republic of China |
| 451.1 |
Transient antibody targeting of CD45RC to prevent the development of acute graft versus host diseases Carole Guillonneau, France |
| 451.4 |
CTLA-4-Ig prolongs graft survival specifically in young but not in old recipients Jasper Iske, Germany |
| 07:30 - 08:15 | Oral Abstracts Session: Organ Preservation and Reperfusion Injury / Repair |
| 452.1 |
Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, improves donor heart recovery after prolonged cold storage in an isolated working rat heart model Jeanette E. Villanueva, Australia |
| 452.2 |
A single-centre, five-year experience with DCD heart transplantation Sarah E Scheuer, Australia |
| 452.3 (P-4.59 in Journal) |
NAPLES study (Normothermic machine perfusion of the liver to enable the sickest first): Preliminary results Hanns Lembach, United Kingdom |
| 452.4 |
Enhanced functional recovery of hearts donated after circulatory death (DCD) with ante-mortem heparin. Ling Gao, Australia |
| 07:30 - 08:15 | Oral Abstracts Session: Education and Vascularized Composite Allograft |
| 453.4 |
Organ donation innovative strategies for Southeast Asia: ODISSeA María Paula Gómez, Spain |
| 453.5 (P-5.02 in Journal) |
EUDONORGAN – Innovative European project training and social awareness for increasing organ donation Marti Manyalich Vidal, Spain |
| 453.2 |
Adipose derived mesenchymal stem cell delivered endothelial protection during graft vasculopathy during vascularized composite tissue allotransplantation Pranitha Kamat, Switzerland |
| 453.3 |
Desensitization using costimulatory blockade and bortezomib in reconstructive transplantation Byoung Chol Oh, United States |
| 13:00 - 14:30 | Workshop Session: Determination of Death in Organ Donation |
| 476.1 |
MAID in Canada Matthew J Weiss, Canada |
| 476.2 |
Global project on death determination Gene Sung, United States |
| 13:00 - 14:30 | Workshop Session: CMV - What's New |
| 477.3 |
New risks for CMV in solid organ and stem cell transplant recipients José Maria Aguado, Spain |
| 477.1 |
New drugs against an old foe Francisco M Marty, United States |
| 477.2 |
Immune monitoring Camille Nelson Kotton, United States |
| 14:30 - 15:15 | Oral Abstracts Session: Donation Issues |
| 481.4 |
Evaluation of the mechanism of action of hepatic hypothermic oxygenated machine perfusion (HOPE) using microdialysis in a clinical setting Damiano Patrono, Italy |
| 481.1 |
Consent to organ offers from public health service “increased risk” donors decreases time to transplant and waitlist mortality Yvonne Kelly, United States |
| 481.2 |
Executive order on advancing american kidney health: A Markov analysis of long-term costs Rashikh A Choudhury, United States |
| 481.3 |
Outcomes of non-liver solid organ transplantation using hepatitis C positive donors to hepatitis C negative recipients: A multicenter experience Kristen L Ryland, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Sex as an Immunological Variable |
| 490.3 |
The role of the X chromosome in organ transplantation Anette Melk, Germany |
| 490.1 |
Improved renal ischemia tolerance in females influences kidney transplantation outcomes Matthew Levine, United States |
| 490.2 |
Sex as a biological variable Stefan G. Tullius, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Paediatric Transplantation Around the World |
| 491.1 |
Paediatric kidney transplantation around the world Mignon McCulloch, South Africa |
| 491.2 |
Cost Effective Immunosuppressive Medications Around the World Katherine Twombley, United States |
| 491.3 |
Variety of vaccine preventive paediatric infectious diseases around the world Lara Danziger-Isakov, United States |
| Poster Session: Anesthesia Management and Critical Care |
| P-1.02 |
Intraoperative low-dose dexmedetomidine attenuates hepatic ischemia-reperfusion injury in pediatric living donor liver transplantation Liang Zhang, People's Republic of China |
| P-1.05 |
Nutritional management to avoid metabolic decompensation at major surgeries in a patient with propionic acidemia related cardiomyopathy: A case report Hiromi Takenaka, Japan |
| P-1.03 |
Clinical outcomes of influenza infection among solid organ transplant recipients in ICU Pinar Zeyneloglu, Turkey |
| P-1.04 |
Solid organ transplant recipients with pneumonia in intensive care unit: A single center study Pinar Zeyneloglu, Turkey |
| Poster Session: Cellular and Regenerative Therapies |
| P-3.06 |
Generation of stable human induced regulatory T-cells requires optimal rapamycin concentration and TCR stimulation Juewan Kim, Australia |
| P-3.11 |
Small-for-size syndrome is characterized with PD-L1 upregulation in macrophage and blocking PD-L1 accelerates liver regeneration Ji-Hua Shi, People's Republic of China |
| P-3.14 |
Directed differentiation of iPS into imDCs under the action of SN can induce immunoreactivity in vitro Cuixiang Xu, People's Republic of China |
| P-3.15 |
Sinomenine enhances imDC derived from IPS cell-directed differentiation to induce transplant immune hyporesponsiveness in mouse Cuixiang Xu, People's Republic of China |
| P-3.03 |
Cell therapy using CD8+Tregs in human transplantation Séverine Bézie, France |
| P-3.10 |
Bile duct reconstruction using scaffold-free tubular constructs created by a Bio-3D Printer for transplantation Takashi Hamada, Japan |
| P-3.13 |
Visual rehabilitation after penetrating keratoplasty Leyla Asena, Turkey |
| P-3.16 |
Limbal stem cell transplantation for restoration of the ocular surface health in bilateral limbal stem cell deficiency Dilek Dursun Altinors, Turkey |
| P-3.01 |
Mass Cytometry Analysis of the Peripheral Regulatory T cell Compartment after Cellular Therapy in Renal Transplantation Alaa Alzhrani, United Kingdom |
| P-3.08 |
Successful induction of hematopoietic chimerism by MCL-1 and Bcl-2 inhibition without radiation/chemo therapy in nonhuman primates David Ma, United States |
| Poster Session: Donation and Procurement |
| P-4.03 |
Sharing of deceased donor livers in Australia and New Zealand Michael Fink, Australia |
| P-4.04 |
Removing the BMI bias in kidney transplantation: Outcomes of kidney transplantation in patients with BMI >35 Aaron YS Hui, Australia |
| P-4.05 |
Clinician perspectives on factors associated with delayed wait-listing for deceased donor renal transplantation in Australia Lachlan McMichael, Australia |
| P-4.10 |
Missed opportunities for organ donation from potential donors with primary brain tumours in Australia; cohort study 2010-2015 Imogen Thomson, Australia |
| P-4.12 |
Verification of suspected melanomas in deceased organ donor referrals: A population-based cohort study using data-linkage, 2010-2015 Brenda Marie Rosales, Australia |
| P-4.15 |
It’s not too late to donate...Controlled Donation after Circulatory Death (DCD) of lungs up to 24 hours after Withdrawal of Cardio Respiratory Support (WCRS) Katherine Labib, Australia |
| P-4.16 |
Perceived vs. verified risk of cancer transmission from deceased organ donors: a 2010-2015 cohort study using data linkage in New South Wales, Australia James A. Hedley, Australia |
| P-4.51 |
Kidney Paired Donation In Brazil Gustavo Fernandes Ferreira, Brazil |
| P-4.44 |
Health professional level barriers to living donor kidney transplantation: A mixed methods study Renata Iskander, Canada |
| P-4.11 |
A prediction model of delay graft function from deceased donor risk factor: A multi-center study from China Wujun Xue, People's Republic of China |
| P-4.23 |
Organ donation, a new subject developed in China towards professionalism Wenshi Jiang, People's Republic of China |
| P-4.35 |
Asymptomatic donor stones: Management algorithm Anant Kumar, India |
| P-4.24 |
Ten recommendations on approaching next of kin for consenting organ donation; Or How did we manage to increase consent rates by 64%? Omid Ghobadi, Iran (Islamic Republic of) |
| P-4.30 |
National implementation of Persian possible donor detection program: An 8-month efficiency evaluation Ali Etemadi, Iran (Islamic Republic of) |
| P-4.49 |
Minimum incision open donor nephrectomy versus laparoendoscopic single-site donor nephrectomy: A possible safe alternative Kentaro Ide, Japan |
| P-4.32 |
The meaning of kidney transplantation from circulatory death donor in local hospital Shin Do Suh, Korea |
| P-4.41 |
Predictors for renal outcome in living kidney donors: From data of Korean organ transplantation registry Yunmi Kim, Korea |
| P-4.48 |
Living liver donor surgical complication : Single center experience Eun-Kyoung Jwa, Korea |
| P-4.46 |
Laparoscopic left lateral sectionectomy in living liver donors: From the first experience to routine usage Konstantin O. Semash, Russian Federation |
| P-4.19 |
Experiences with expanded criteria donors: 10-year analysis of the Martin, Slovakia Transplant Center Ivana Dedinska, Slovakia (Slovak Republic) |
| P-4.13 |
Impact of controlled donation after circulatory death (cDCD) on waiting list mortality for liver transplantation in the last 10 years: The Spanish experience Felipe Alconchel, Spain |
| P-4.22 |
ISO quality certification for a hospital-based organ procurement unit: The United Arab Emirates (UAE) experience María Paula Gómez, Spain |
| P-4.21 |
Deceased-donor transplantation activities in Turkey Ebru Hatice Ayvazoglu Soy, Turkey |
| P-4.08 |
Deceased kidney donor pre-procurement cardiac arrest associated with better long-term graft survival Shivani Bajpai, United States |
| P-4.18 |
Zero organ, one organ, and authorized-not recovered donors: Trends and opportunities in a growing organ procurement organization Jeffrey P. Orlowski, United States |
| P-4.47 |
Robotic versus open mini incision living donor nephrectomy: Single center experience Seung Duk Lee, United States |
| P-4.84 |
Implementation of a national organ matching and data system for Australian solid organ transplantation programs Rhonda Holdsworth, Australia |
| P-4.100 |
Burnout and resilience among organ donation coordinators: A scoping review Vanessa Silva e Silva, Canada |
| P-4.102 |
Bric study - Burnout and resiliency levels among organ donation coordinators: Research protocol Vanessa Silva e Silva, Canada |
| P-4.61 |
Brain death-mediated inflammatory liver injury is mediated by hepatocytes apoptosis through TRAIL Zhong-kun Huo, People's Republic of China |
| P-4.69 |
Double-lobectomy in rat model of steatotic liver transplantation Fu Zhen, People's Republic of China |
| P-4.73 |
Value of CTGF in assessment of liver graft with non-alcoholic fatty liver disease after brain death Dongjing Yang, People's Republic of China |
| P-4.96 |
Tetramethylpyrazine activated PPARγ in resuscitating the liver graft donated after cardiac death Fu Zhen, People's Republic of China |
| P-4.111 |
Enabling legal provisions and their crucial role in promoting organ donation and transplantation – The Indian scenario Vasanthi Ramesh M.S., FALS, India |
| P-4.70 |
Lessons learned from perfusate analysis during dual hypothermic oxygenated machine perfusion of liver grafts Damiano Patrono, Italy |
| P-4.107 |
Deceased donor tissue recovery activity in Eastern Japan Sayaka Nagashima, Japan |
| P-4.101 |
Causes of lowered family consent rate for organ donation Eunsuk Yu, Korea |
| P-4.87 |
Brain death donation improvement areas: Procurement impact Olga E Facio, Mexico |
| P-4.65 |
Does the cold storage really «cold»? Liver thermography and microdialysis findings Alexander I Sushkov, Russian Federation |
| P-4.74 |
Observations on 24-hour ex situ normothermic liver perfusion Amelia J Hessheimer, Spain |
| P-4.80 |
New technique for abdominal wall retrieval: Our initial outcomes with the new technique in non-vascularized fascia Iago Justo Alonso, Spain |
| P-4.81 |
Quorum: IT tool for organ donation quality system management: Pilot program in the Kingdom of Saudi Arabia Estephan Arredondo, Spain |
| P-4.82 |
Implementation results of the first hospital-based organ procurement unit in Kerala (India) María Paula Gómez, Spain |
| P-4.92 |
Protocol based on hepatitis C virus nucleic acid testing to optimize renal transplant from seropositive donors to seronegative recipients. An European experience antonio franco, Spain |
| P-4.98 |
International Registry In Organ Donation and Transplantation (IRODAT) – 2019 worldwide data María Paula Gómez, Spain |
| P-4.99 |
Heart transplantation from controlled donors: First case report in Spain ALONSO MATEOS RODRIGUEZ, Spain |
| P-4.83 |
Readiness of the retrieval team for deceased donor kidney transplantation in Thailand Korntip Phonphok, Thailand |
| P-4.94 |
Evaluation of one year, five years and ten years life time of patients with kidney transplant: Single-center experience Mehmet Fethullah Aydin, Turkey |
| P-4.110 |
Establishment of solid organ transplantation in the United Arab Emirates Shiva Kumar, United Arab Emirates |
| P-4.112 |
Establishment of liver transplantation in the United Arab Emirates from deceased and living donors Shiva Kumar, United Arab Emirates |
| P-4.62 |
Bridging the gap: normothermic perfusion of discarded livers significantly alleviates the donor shortage in the United States Siavash Raigani, United States |
| P-4.66 |
Real-time viability assessment during normothermic machine perfusion with Raman spectroscopy Reinier de Vries, United States |
| P-4.76 |
Using pulsatile perfusion to successfully transplant kidneys with 15 percent glomerulosclerosis Marty T Sellers, United States |
| P-4.77 |
Deceased donor organ flush with equivalent volumes of HTK and UW at a single U.S. organ procurement organization Richard S. Mangus, United States |
| P-4.79 |
Automated electronic referrals are changing donation Wade Liu, United States |
| P-4.89 |
Salvaging discarded livers with normothermic machine perfusion: Is it worth the cost? Reinier de Vries, United States |
| P-4.95 |
Liver transplantation of hepatitis C-viremic donors to hepatitis C naive recipients Fidel Lopez-Verdugo, United States |
| P-4.97 |
Aggressive pursuit of liver only donors and their transplant outcomes: Should we continue? Marty T Sellers, United States |
| P-4.109 |
Pancreas transplant in chronic kidney disease for type 1 diabetic patients Rashikh A Choudhury, United States |
| P-4.85 |
Robotic versus laparoscopic living donor nephrectomy: A prospective study Thanh-Tuan Nguyen, Viet Nam |
| Poster Session: Histocompatibility |
| P-7.07 |
Assessment of ABO-histocompatibility: Modernizing ABO antibody detection tools for use in transplantation Anne Halpin, Canada |
| P-7.10 |
Can epitope matching outmatch traditional HLA matching? Christian Unterrainer, Germany |
| P-7.04 |
Prospective de novo DSA monitoring in renal transplant patients Efstratios Kasimatis, Greece |
| P-7.05 |
Angiotensin II Type 1 Receptor Antibodies: Risk for rejection and impaired graft function Angeliki G. Vittoraki, Greece |
| P-7.14 |
Tregs monitoring before and after renal transplantation Efstratios Kasimatis, Greece |
| P-7.06 |
Impact of delayed graft function on highly sensitized patients in deceased donor kidney transplantation Seong Gyu Kim, Korea |
| P-7.12 |
Evaluation of a novel ultra-high-resolution assay and analytic software for next generation sequencing based genotyping of 11 human leukocyte antigen loci MIMI JANG, Korea |
| P-7.02 |
Medium to long term impact of pre transplant DSA on allograft outcomes in deceased donors transplants Muhammad A Khurram, United Kingdom |
| P-7.08 |
Impact of induction regimen, human leukocyte antigen mismatches and steroid maintenance on recipient and graft survival with different glomerulonephridities Samy M Riad, United States |
| Poster Session: Histopathology |
| P-8.04 |
The causes and clinical significance of cellular or fibrocellular crescents in renal allograft Sung-Eun Choi, Korea |
| Poster Session: Sex and Gender in Transplantation |
| P-15.06 |
Living donor kidney transplantation: Overcoming sex disparity in Japan Mikiko Yoshikawa, Japan |
| P-15.01 |
Pregnancy outcomes in 1164 female kidney transplant recipients Lisa Coscia, United States |
| P-15.04 |
Is altruistic (non-directed) living kidney donation a realm of Caucasian females? Experience from a single center in the United States Amit Sharma, United States |
| Poster Session: Transplant Complications |
| P-17.03 |
Spectrum and consistency of cancer outcomes in randomized trials in kidney transplant recipients: A systematic review Eric Au, Australia |
| P-17.01 |
Risk of hematological malignancies in solid organ transplant recipients: a meta-analysis Runchen Wang, People's Republic of China |
| P-17.08 |
The evaluation of safety and efficacy of PCSK9 inhibitor in patients with cardiac allograft vasculopathy and hypercholesterolemia Kensuke Kuroda, Japan |
| P-17.07 |
NT-pro BNP, visceral fat area, cell membrane integrity and arterial stiffness in renal transplant recipients Zbigniew Heleniak, Poland |
| P-17.06 |
Role of sex in post-transplant diabetes mellitus development: Are men and women equal? Ivana Dedinska, Slovakia (Slovak Republic) |
| P-17.05 |
Thyroid cancer recurrence risk after transplantation: Single center experience Neslihan Bascil Tutuncu, Turkey |
| Poster Session: Transplant Immunosuppression |
| P-18.02 |
Mycophenolate mofetil and the incidence of skin cancer in kidney transplant recipients Sarah J. Yusuf, Nigeria |
| P-18.38 |
Feasibility of steroid-free tacrolimus-basiliximab immunosuppression in pediatric liver transplantation Natalia Riva, Argentina |
| P-18.24 |
Effects of immunosuppression and adjuvant immune-targeted drugs in preventing HCC recurrence after liver transplantation HAO XING, People's Republic of China |
| P-18.34 |
The feature of MDSCs in the long-term stable kidney transplant recipients after different immunosuppression therapy Tian Puxun, People's Republic of China |
| P-18.05 |
Intensified vs. standard mycophenolate dosing during the first year after kidney transplantation Mladen Knotek, Croatia |
| P-18.08 |
Once- versus twice-daily tacrolimus and graft survival Christian Unterrainer, Germany |
| P-18.35 |
Athena vs Hephaistos - Are discontinuation rates in multicenter studies driven by facts or attitudes? Björn Nashan, Germany |
| P-18.26 |
Mammalian target of rapamycin Inhibitors after post-transplant hepatocellular carcinoma recurrence: Is it too late? Kin Pan Au, Hong Kong |
| P-18.40 |
Safety and efficacy of everolimus in maintenance kidney transplant patients: A 2-year post-marketing surveillance study in Japan Yoko Watanabe, Japan |
| P-18.22 |
Clinical study of standard- versus reduced-dose tacrolimus combined with generic mycophenolate mofetil in de novo kidney transplantation: A prospective randomized trial Jun Bae Bang, Korea |
| P-18.28 |
Efficacy and safety of everolimus with reduced-exposure cyclosporine in de novo kidney transplant recipients: 24-month <em>post-hoc</em> analysis from the TRANSFORM study Duck Jong Han, Korea |
| P-18.37 |
Efficacy and safety of everolimus in Korean kidney transplant recipients: Results from a prospective, open label, multicenter, single arm trial Man Ki Ju, Korea |
| P-18.16 |
Kidney re-transplant: Single-center experience from MENA region Osama Gheith, Kuwait |
| P-18.18 |
Single centre experience on ultra low dose Thymoglobulin as an induction agent in low immunological risk living kidney transplant recipients Maisarah Jalalonmuhali, Malaysia |
| P-18.17 |
Unusual approach to assess induction therapy efficacy in kidney transplantation Michael Kaabak, Russian Federation |
| P-18.36 |
Outcomes of everolimus after heart transplantation Maria Simonenko, Russian Federation |
| P-18.25 |
High intrapatient variability of tacrolimus exposure after liver transplantation as new marker of poor outcomes CRISTINA DOPAZO, Spain |
| P-18.31 |
Analysis of Immunobiogram pharmacodynamic dose-response curves to immunosuppressants in kidney transplant recipients: Further results from Transbio Study Julio Pascual, Spain |
| P-18.32 |
Milligram to milligram conversion of twice daily to once daily tacrolimus provides equivalent drug exposure in adult kidney transplant Kanitha Tiankanon, Thailand |
| P-18.04 |
Management of peripheral facial palsy in kidney transplant patients: A case series Malek Mojaat, Tunisia |
| P-18.03 |
The incidence of glucose impairment and new onset diabetes (NODAT) after renal transplant: A retrospective 12-month review at a single UK-centre. John T Black, United Kingdom |
| P-18.15 |
Comparison of single-dose vs double dose Alemtuzumab in renal transplant recipients: A single centre experience Avinash R Odugoudar, United Kingdom |
| P-18.06 |
Pediatric primary deceased-donor-kidney transplant-recipients outcomes by immunosuppression induction received in the United States Samy M Riad, United States |
| P-18.07 |
Pediatric primary live-donor-kidney transplant-recipients outcomes by immunosuppression induction received in the United States Samy M Riad, United States |
| Poster Session: Vascularized Composite Allotransplantation |
| P-20.01 |
Subcutaneous implantation of rapamycin impregnated scaffolds demonstrate the potential for localised islet graft immunosuppression Francis Kette, Australia |
| P-20.03 |
Local delivery of FK506 to prevent VCA early acute rejection in a delayed mixed chimerism protocol Marion P Goutard, United States |
